Replies to post #659408 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Sticky this one.

Also used to get to the bottom of it.

>>I’m hanging on to my remaining shares incase a carrot appears but I have come to the realization it probably isn’t going to.

-------

Seems to indicate that the Street knows this management team with their gobs of currently in-the-money and true-up options will continue to dilute retail to death.

And, now no official milestones as per the latest filing. Hmmm. So perhaps either a buyout or reverse split with a new trial, which will it be?

>>Let’s look at all the mile stones since 2018 that were supposed to take this stock “to the moon” and “create generational wealth” these are in chronological order and the price keeps going down. Look out below :-)

Data lock ~$2.50
TLD~$1.80
journal~$1.20
Submittal~$.80 I’m guessing acceptance will be lower if it gets there.

[XMaster2023]

Dangling Carrot? Submission to MMA 12/20/23?

[TTsr]

Funny, but you don’t include denied MTD & Discovery in your SP analysis?

[SkyLimit2022]

Legend,

Unfortunating, it appears that your posts are defamatory and baseless. The AI bs detector has once again identified your post as bs.





“This statement is greater than 99% innuendo and conjecture.

1. **Accusations of Manipulation**: The claim that company executives are manipulating retail investors is a serious accusation and would require substantial evidence, which is not provided.

2. **Hypothetical Scenario ("Carrot")**: The metaphor of "dangling a carrot" is used to imply false promises or unachievable goals. However, this is presented without specific evidence to substantiate the claim.

3. **Stock Price Speculation**: The correlation of company milestones with declining stock prices is noted, but stock prices can be influenced by many factors, not just company performance or news. The statement doesn't account for these complexities.

4. **Predictive Assertions**: The predictions about future stock prices, including post-approval scenarios, are speculative and not backed by any analysis.

5. **Negative Comparison**: Drawing a parallel with another company's experience (Outlook Therapeutics) is anecdotal nonsense and does not constitute a logical reason to expect similar outcomes.

Overall, the statement is nonsensical and does not present any logical argument or evidence-based analysis of the company's actions or stock performance.”



https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

[The Danish Dude]

Please do continue ignoring +6 years of evidence of spoofing - and probably with naked shorting on top - instigated by your employers and with you and other stock board pawns following out their orders.

As you non investigated lot usually do.